David Loc Tran, MD
Hospice/Palliative Care · Encinitas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Scripps Health Inpatient Providers Medical Group Inc · 209 clinicians in this group
Looking this up.
Hospitals listed: Scripps Mercy Hospital. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tran’s office at (760) 633-6501 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A139964 · Current
Licensed to practise in California · since 2015 · expires 2027-12-31 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Scripps Mercy HospitalSan Diego, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Scripps Health, which runs 5 hospitalsPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.428, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.167, Oct 2024 – Sep 2025
See every measure and the patient survey for Scripps Mercy Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 1 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.428 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.167 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.62 (0.69 to 2.56) · 1,395 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.64 to 1.21) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 140.2 (94.53 to 185.86) · 118 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 115 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 400 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 388 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 503 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 5,575 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 8,056 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.12 to 0.49) · 8,169 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.77 (1.85 to 5.69) · 1,962 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.26 (0 to 2.77) · 666 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.52 (2.12 to 4.93) · 1,824 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.77 (1.62 to 13.93) · 707 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.17 (3.71 to 10.62) · 678 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 345 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.11 (0 to 0.66) · 6,094 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 389 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.646 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.086 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.034 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 291 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 1,123 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -2.7 · 104 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 9.2 · 472 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 19.3 · 411 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.6 · 851 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5.1 to 10) · 229 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.6 to 16) · 229 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 392 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 350 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 15 (11.3 to 19.9) · 480 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 264 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,127 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$40,737
Medicare paid this office $40,737 for 125 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 46 | $16,973 | $152 |
| New patient visit (60+ min) | 49 | $8,948 | $183 |
| Return visit (30+ min) | 24 | $4,344 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $3,727 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,219 | $140 |
See all 7 services
| Long return visit (40+ min) | 46 | $16,973 | $152 |
| New patient visit (60+ min) | 49 | $8,948 | $183 |
| Return visit (30+ min) | 24 | $4,344 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $3,727 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,219 | $140 |
| Advance care planning, first 30 minutes | 18 | $1,347 | $61 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 14 | $189 | $14 |
Who their Medicare patients are
125 Original Medicare patients in 2024. Average age 76 · Women 53% · Also on Medicaid 26% · Health risk score 3.10. Above the middle of the specialty; the typical hospice and palliative care clinician is at 2.98.
Conditions among them: High blood pressure 75% · Diabetes 46% · Chronic kidney disease 43% · Coronary heart disease 42% · Depression 42% · Heart failure 38% · Cancer 38% · Atrial fibrillation 31% · Dementia 26% · COPD 25% · Stroke 18%.
The office billed $133,256, Medicare allowed $51,435 and paid $40,737; for 321 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 125 | 321 | 76 | 3.10 | $133,256 | $40,737 |
| 2023 | 93 | 222 | 79 | 3.36 | $91,586 | $28,574 |
| 2022 | 103 | 219 | 83 | 2.79 | $95,136 | $24,963 |
| 2021 | 121 | 398 | 84 | 2.31 | $170,790 | $53,801 |
| 2020 | 106 | 302 | 83 | 2.26 | $124,088 | $39,270 |
| 2019 | 133 | 401 | 82 | 2.50 | $188,144 | $54,486 |
| 2018 | 58 | 138 | 82 | 2.06 | $60,546 | $19,466 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Long return visit (40+ min) | 25 | $9,582 | $152 |
| New patient visit (60+ min) | 35 | $6,395 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $4,113 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,071 | $146 |
| Return visit (30+ min) | 15 | $2,118 | $111 |
| Advance care planning, first 30 minutes | 25 | $1,660 | $64 |
2022: 8 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 22 | $4,613 | $144 |
| Long return visit (40+ min) | 23 | $3,879 | $149 |
| Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | 14 | $2,493 | $138 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 22 | $2,234 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,986 | $166 |
| Return visit (30+ min) | 11 | $1,779 | $99 |
| Advance care planning, first 30 minutes | 21 | $1,753 | $76 |
| Advance care planning, first 30 minutes | 17 | $1,070 | $63 |
2021: 8 services
| Long return visit (40+ min) | 38 | $17,710 | $170 |
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 40 | $11,588 | $152 |
| Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | 18 | $4,519 | $167 |
| Advance care planning, first 30 minutes | 47 | $3,916 | $82 |
| Return visit (30+ min) | 15 | $2,803 | $127 |
| Residence visit for new patient with moderate level of medical decision making, per day at least 60 minutes | 18 | $2,578 | $143 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 18 | $2,430 | $110 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,722 | $101 |
2020: 8 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 55 | $16,379 | $152 |
| Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | 20 | $5,471 | $152 |
| Telephone medical discussion with physician, 21-30 minutes | 23 | $4,694 | $107 |
| Long return visit (40+ min) | 19 | $3,202 | $128 |
| Residence visit for new patient with moderate level of medical decision making, per day at least 60 minutes | 19 | $3,086 | $162 |
| Extended office or other outpatient service, first hour | 12 | $1,470 | $123 |
| Advance care planning, first 30 minutes | 15 | $1,217 | $81 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $1,105 | $69 |
2019: 8 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 55 | $20,818 | $153 |
| Long return visit (40+ min) | 25 | $8,196 | $134 |
| Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | 21 | $8,141 | $163 |
| Extended office or other outpatient service, first hour | 36 | $4,243 | $118 |
| Advance care planning, first 30 minutes | 37 | $3,251 | $77 |
| Residence visit for new patient with moderate level of medical decision making, per day at least 60 minutes | 15 | $2,423 | $162 |
| Residence visit for new patient with high level of medical decision making, per day at least 75 minutes | 11 | $2,054 | $187 |
| New patient visit (60+ min) | 11 | $1,930 | $175 |
2018: 2 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 24 | $8,264 | $159 |
| Extended office or other outpatient service, first hour | 21 | $2,609 | $119 |
Drugs they prescribed that Part D paid
$23,621
Pharmacies billed $23,621 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 54% of their Part D prescriptions (188 of 350) in 2024. Above the middle of the specialty; the typical hospice and palliative care clinician is at 43%. Long-acting opioids: 40% of their opioid prescriptions.
318 generic and 32 brand-name prescriptions · $23,621 in drug cost · 15 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine | 25 | $6,448 | $258 |
| Oxycodone | 51 | $1,178 | $23 |
| Hydrocodone-Acetaminophen | 19 | $716 | $38 |
| Hydromorphone | 15 | $461 | $31 |
| Methadone | 20 | $345 | $17 |
See all 9 drugs
| Buprenorphine | 25 | $6,448 | $258 |
| Oxycodone | 51 | $1,178 | $23 |
| Hydrocodone-Acetaminophen | 19 | $716 | $38 |
| Hydromorphone | 15 | $461 | $31 |
| Methadone | 20 | $345 | $17 |
| Gabapentin | 27 | $344 | $13 |
| Morphine Sulfate | 22 | $268 | $12 |
| Duloxetine | 14 | $188 | $13 |
| Lorazepam | 33 | $152 | $5 |
Year by year
| 2024 | 350 | 78 | 54% (188) | 9% | $23,621 |
| 2023 | 236 | 67 | 54% (127) | 13% | $16,742 |
| 2022 | 336 | 65 | 18% (59) | 7% | $14,110 |
| 2021 | 563 | 88 | 32% (178) | 8% | $30,256 |
| 2020 | 472 | 90 | 29% (135) | 15% | $25,397 |
| 2019 | 268 | 69 | 28% (76) | 15% | $12,627 |
| 2018 | 55 | 25 | 24% (13) | None | $1,612 |
| 2017 | 41 | 21 | None | None | $632 |
| 2016 | 30 | 20 | 60% (18) | None | $650 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Oxycontin | 11 | $8,731 | $794 |
| Oxycodone | 44 | $780 | $18 |
| Mirtazapine | 12 | $565 | $47 |
| Hydromorphone | 19 | $321 | $17 |
| Quetiapine | 11 | $192 | $17 |
| Morphine Sulfate | 12 | $151 | $13 |
| Gabapentin | 14 | $147 | $11 |
| Lorazepam | 22 | $101 | $5 |
2022: 9 drugs
| Eliquis | 14 | $7,840 | $560 |
| Quetiapine | 72 | $1,334 | $19 |
| Gabapentin | 34 | $383 | $11 |
| Methadone | 20 | $353 | $18 |
| Sertraline | 14 | $301 | $21 |
| Hydrocodone-Acetaminophen | 16 | $261 | $16 |
| Clonazepam | 13 | $140 | $11 |
| Lorazepam | 11 | $33 | $3 |
| Metoprolol | 13 | $23 | $2 |
2021: 12 drugs
| Eliquis | 14 | $8,275 | $591 |
| Mirtazapine | 21 | $1,041 | $50 |
| Hydrocodone-Acetaminophen | 46 | $935 | $20 |
| Gabapentin | 35 | $869 | $25 |
| Quetiapine | 39 | $728 | $19 |
| Methadone | 50 | $543 | $11 |
| Oxycodone | 22 | $297 | $14 |
| Lorazepam | 48 | $290 | $6 |
| Morphine Sulfate | 11 | $201 | $18 |
| Buspirone | 11 | $201 | $18 |
| Clonazepam | 20 | $126 | $6 |
| Tramadol | 11 | $27 | $2 |
2020: 14 drugs
| Eliquis | 13 | $5,904 | $454 |
| Quetiapine | 51 | $865 | $17 |
| Mirtazapine | 19 | $828 | $44 |
| Hydrocodone-Acetaminophen | 36 | $705 | $20 |
| Sertraline | 21 | $331 | $16 |
| Morphine Sulfate | 16 | $294 | $18 |
| Methadone | 24 | $286 | $12 |
| Oxycodone | 19 | $248 | $13 |
| Gabapentin | 11 | $183 | $17 |
| Trazodone | 16 | $174 | $11 |
| Atenolol | 13 | $162 | $12 |
| Lorazepam | 39 | $152 | $4 |
| Tramadol | 20 | $77 | $4 |
| Amlodipine Besylate | 11 | $40 | $4 |
2019: 7 drugs
| Morphine Sulfate Er | 13 | $1,117 | $86 |
| Morphine Sulfate | 17 | $1,065 | $63 |
| Quetiapine | 19 | $365 | $19 |
| Hydrocodone-Acetaminophen | 19 | $334 | $18 |
| Trazodone | 15 | $258 | $17 |
| Gabapentin | 11 | $219 | $20 |
| Sertraline | 16 | $197 | $12 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 12 | $266 | $22 |
Money from drug and device companies
$267 in 2025
| 2025 | 4 | 4 | None | $267 |
| 2024 | 1 | 1 | None | $31 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Davol | Phasix Mesh | $174 | 1 payment
|
| PharmaEssentia USA | Besremi | $34 | 1 payment
|
| Novartis Pharmaceuticals | Kisqali | $31 | 1 payment
|
| Incyte | Jakafi | $28 | 1 payment
|
See all 4 published payments
| PharmaEssentia USA | Meals · 2025-11-14 | Besremi | $34 |
| Novartis Pharmaceuticals | Meals · 2025-11-12 | Kisqali | $31 |
| Incyte | Meals · 2025-11-05 | Jakafi | $28 |
| Davol | Meals · 2025-09-28 | Phasix Mesh | $174 |
See earlier years (2024)
2024: $31
| Blue Earth Diagnostics | Posluma | $31 | 1 payment
|
Professional record
- NPI
- 1154740819
- Licence
- CA A139964California A139964: Current · expires 2027-12-31
- Trained
- University of California, Irvine, California College of Medicine, 2014
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207QH0002X (207QH0002X)
- Mailing address
- 2350 W El Camino Real Fl 2, Mountain View, CA, 94040
- NPI first listed
- 2014-04-09
- NPI last updated
- 2018-12-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 795 El Camino Real, Palo Alto, CA, 94301